Posts

Showing posts with the label antibodies

Scientists capture images of antibodies attacking neuron receptors

Using the UT Southwestern Cryo-Electron Microscopy Facility, researchers have for the first time captured images of autoantibodies bound to nerve cell surface receptors, revealing the physical mechanisms behind neurological autoimmune disease. The findings, published in Cell, could lead to new ways to diagnose and treat autoimmune conditions, the study authors said. “We are entering a new era of understanding how autoimmune diseases work in the central nervous system,” says Colleen M. Noviello, Ph.D., Assistant Professor of Neuroscience at UTSW who specializes in obtaining cryo-electron microscopy (cryo-EM). ) images up to atomic resolution. Dr. Noviello led the research with Ryan Hibbs, Ph.D., Associate Professor of Neuroscience and Biophysics, Effie Marie Cain Scholar in Medical Research, and Investigator Peter O’Donnell Jr. Brain Institute and Harald Prüss of the Universitätsmedizin Berlin. Researchers have studied autoimmune diseases — a class of conditions in which the immune

Science News | Researchers Analyze Structure of Antibodies That Could Hold Key to More Effective Cancer Treatments | NewestLY

Southampton [UK]July 10 (ANI): In the fight against Cancer, new insights into the key properties of antibodies have been discovered by researchers at the University of Southampton. The interdisciplinary study, published in Science Immunology, reveals how changing the flexibility of antibodies can stimulate a stronger immune response. Read Also | Guru Purnima 2022 Date and Time in India: Know Tithi, Its Customs and Importance of Celebrating the Birthday of the Great Vedic Saint Vyasa. These findings enabled the Southampton team to design antibodies to activate important receptors on immune cells to “turn them on” and provide a more potent anti-cancer effect. The scientists believe their findings could pave the way for improving antibody drugs that target cancer as well as other autoimmune diseases. Read Also | 2022 Wimbledon Final: Novak Djokovic Lifts 21st Grand Slam Title. In the study, the team investigated antibody drugs that target the CD40 receptor for cancer treatment. Clinica

Researchers analyzed the structure of antibodies that could be key to more effective cancer treatments

Researchers at the University of Southampton have gained unprecedented new insights into the key properties of antibodies needed to fight cancer. The interdisciplinary study, published in Science Immunology, reveals how changing the flexibility of antibodies can stimulate a stronger immune response. These findings enabled the Southampton team to design antibodies to activate important receptors on immune cells to “turn them on” and provide a more potent anti-cancer effect. The scientists believe their findings could pave the way for improving antibody drugs that target cancer as well as other autoimmune diseases. In the study, the team investigated antibody drugs that target the CD40 receptor for cancer treatment. Clinical development is hampered by a lack of understanding of how to stimulate receptors to appropriate levels. The problem is that if the antibodies are overactive, they can become toxic. Previous Southampton studies have shown that a specific type of antibody called IgG2